Tumor-Induced Osteomalacia von Florenzano, Pablo, Hartley, Iris R., Jimenez, Macarena, Roszko, Kelly, Gafni, Rachel I., Collins, Michael T.

Volltext

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia von Hartley, Iris R., Roszko, Kelly L., Li, Xiaobai, Pozo, Karen, Streit, Jamie, Rivero, Jaydira, Magone, M. Teresa, Smith, Michaele R., Vold, Roo, Dambkowski, Carl L., Collins, Michael T., Gafni, Rachel I.

Volltext

Burosumab for Tumor‐Induced Osteomalacia: Not Enough of a Good Thing von Hartley, Iris R, Collins, Michael T

Volltext

Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia von Hartley, Iris R, Miller, Carole B, Papadakis, Georgios Z, Bergwitz, Clemens, Del Rivero, Jaydira, Blau, Jenny E, Florenzano, Pablo, Berglund, Jason A, Tassone, Jing, Roszko, Kelly L, Moran, Susan, Gafni, Rachel I, Isaacs, Randi, Collins, Michael T

Volltext

A Cross‐Sectional Cohort Study of the Effects of FGF23 Deficiency and Hyperphosphatemia on Dental Structures in Hyperphosphatemic Familial Tumoral Calcinosis von Lee, Alisa E, Chu, Emily Y, Gardner, Pamela J, Duverger, Olivier, Saikali, Amanda, Wang, Sean K, Gafni, Rachel I, Hartley, Iris R, Ten Hagen, Kelly G, Somerman, Martha J, Collins, Michael T

Volltext

Structural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis von Sheppard, Aaron J, Paravastu, Sriram S, Farhadi, Faraz, Donnelly, Eve, Hartley, Iris R, Gafni, Rachel I, Saboury, Babak, Collins, Michael T, Roszko, Kelly L

Volltext

Autosomal Dominant Hypocalcemia Type 1: A Systematic Review von Roszko, Kelly L, Stapleton Smith, Lyndsay M, Sridhar, Ananth V, Roberts, Mary Scott, Hartley, Iris R, Gafni, Rachel I, Collins, Michael T, Fox, Jonathan C, Nemeth, Edward F

Volltext

Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1 von Gafni, Rachel I., Hartley, Iris R., Roszko, Kelly L., Nemeth, Edward F., Pozo, Karen A., Lombardi, Ed, Sridhar, Ananth V., Roberts, Mary S., Fox, Jonathan C., Collins, Michael T.

Volltext

Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI) von Ferreira, Carlos R., Hackbarth, Mary E., Ziegler, Shira G., Pan, Kristen S., Roberts, Mary S., Rosing, Douglas R., Whelpley, Margaret S., Bryant, Joy C., Macnamara, Ellen F., Wang, Sisi, Müller, Kerstin, Hartley, Iris R., Chew, Emily Y., Corden, Timothy E., Jacobsen, Christina M., Holm, Ingrid A., Rutsch, Frank, Dikoglu, Esra, Chen, Marcus Y., Mughal, M. Zulf, Levine, Michael A., Gafni, Rachel I., Gahl, William A.

Volltext

Consideration of ICD-9 Code-Derived Disease-Specific Safety Indicators in CKD von Hartley, Iris R, Ginsberg, Jennifer S, Diamantidis, Clarissa J, Zhan, Min, Walker, Loreen, Rattinger, Gail B, Fink, Jeffrey C

Volltext

Determination of FGF23 Levels for the Diagnosis of FGF23‐Mediated Hypophosphatemia von Hartley, Iris R., Gafni, Rachel I., Roszko, Kelly L., Brown, Sydney M., Castro, Luis F., Saikali, Amanda, Ferreira, Carlos R., Gahl, William A., Pacak, Karel, Blau, Jenny E., Boyce, Alison M., Salusky, Isidro B., Collins, Michael T., Florenzano, Pablo

Volltext

PTH and FGF23 Exert Interdependent Effects on Renal Phosphate Handling: Evidence From Patients With Hypoparathyroidism and Hyperphosphatemic Familial Tumoral Calcinosis Treated Wit... von Ovejero, Diana, Hartley, Iris R, Castro Diaz, Luis Fernandez, Theng, Elizabeth, Li, Xiaobai, Gafni, Rachel I, Collins, Michael T

Volltext

Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor von Magone, M. Teresa, Hartley, Iris R., Fitzgibbon, Edmond, Bishop, Rachel, Arango, Mike, Moran, Susan, Vold, Roo, Rivero, Jaydira del, Pozo, Karen, Streit, Jamie, Roszko, Kelly L., Collins, Michael T., Gafni, Rachel I.

Volltext

Fracture Risk in Pediatric Patients With MEN2B von Li, Iris, Hartley, Iris R, Klubo-Gwiedzdzinska, Joanna, Reynolds, James C, Thomas, Barbara J, Hogan, Julie, Enyew, Mahider M, Dombi, Eva, Ling, Alexander, Akshintala, Srivandana, Venzon, David J, Del Rivero, Jaydira, Collins, Michael, Glod, John W

Volltext

Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation von Abdul Sater, Zahraa, Jha, Abhishek, Hamimi, Ahmed, Mandl, Adel, Hartley, Iris R, Gubbi, Sriram, Patel, Mayank, Gonzales, Melissa, Taïeb, David, Civelek, Ali Cahid, Gharib, Ahmed M, Auh, Sungyoung, O’Mara, Alana E, Pacak, Karel, Cypess, Aaron M

Volltext

Hyperphosphatemic Familial Tumoral Calcinosis Hidden in Plain Sight for 73 Years: A Case Report von Lee, Alisa E., Hartley, Iris R., Roszko, Kelly L., Vanek, Chaim, Gafni, Rachel I., Collins, Michael T.

Volltext

Encaleret Normalized Mineral Homeostasis in Autosomal Dominant Hypocalcemia Type 1 (ADH1) in a Phase 2 Study: FR-OR08 von Roszko, Kelly, Gafni, Rachel, Hartley, Iris R., Nemeth, Edward F., Pozo, Karen A., Lombardi, Ed, Roberts, Mary S., Adler, Scott H., Collins, Michael

Volltext

Reply von Magone, M. Teresa, Hartley, Iris R., FitzGibbon, Edmond, Bishop, Rachel, Arango, Mike, Moran, Susan, Vold, Roo, Rivero, Jaydira del, Pozo, Karen, Streit, Jamie, Roszko, Kelly L., Collins, Michael T., Gafni, Rachel I.

Volltext

Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia von Hartley, Iris R, Miller, Carole B, Papadakis, Georgios Z, Bergwitz, Clemens, del Rivero, Jaydira, Blau, Jenny E, Florenzano, Pablo, Berglund, Jason A, Tassone, Jing, Roszko, Kelly L, Moran, Susan, Gafni, Rachel I, Isaacs, Randi, Collins, Michael T

Volltext

Reply von Magone, M Teresa, Hartley, Iris R, FitzGibbon, Edmond, Bishop, Rachel, Arango, Mike, Moran, Susan, Vold, Roo, Rivero, Jaydira Del, Pozo, Karen, Streit, Jamie, Roszko, Kelly L, Collins, Michael T, Gafni, Rachel I

Volltext